19.7 C
Buenos Aires
viernes 16 abril 2021 04:04
Inicio Etiquetas Investment

Etiqueta: investment

B. Braun opens €30 million plant

English version Argentina following the rest of the world and has ordered drugmakers to produce parenteral preparations exclusively through closed system technology. To meet the ANMAT's new regulations, Germany's B. Braun is investing €30 million to build a new plant in Mar del Plata to produce for the local market. German drugmaker...

Pharma review of the year 2017

English version The "un-termination" of the agreement with PAMI, Argentina’s state funded health provision for pensioners, was possibly the key and most controversial topic of 2017. The agreement was terminated then reactivated in a series of twists that have left many wondering what lays in store for the next agreement due...

German drugmaker Stada buys Argentine generics producer

The post-Davos influx of foreign investment appears to be arriving more quickly than expected, starting with German drugmaker Stada's purchase of Argentine generics producer Vannier. English Version The post-Davos influx of foreign investment appears to be arriving more quickly than expected, starting with German drugmaker Stada's purchase of Argentine generics producer Vannier. See website. The transaction, completed...

Eurofarma buys Sanofi Argentine plant

English Version Brazilian firm Eurofarma has bought Sanofi’s plant in Lomas del Mirador, Argentina. The decision comes after a long process of due diligence in which the company, overseen by Mauricio Billi, looked closely at its figures. Brazilian firm Eurofarma has bought Sanofi’s plant in Argentina. The decision comes after a long process of due diligence in which the company, overseen...

Savant opens new plant

The Argentine pharmaceutical company Savant has cut the ribbon at a new softgel capsule plant in the town of El Tío, Córdoba. English version In Córdoba– The Argentine pharmaceutical company Savant has cut the ribbon at a new softgel capsule plant in the town of El Tío, Córdoba. During a tour of...

Abbott acquires Recalcine

US pharma company Abbott has completed its acquisition of Chilean firm CFR Recalcine, doubling its presence in the Latin American generics market. English version US pharma company Abbott has completed its acquisition of Chilean firm CFR Recalcine, doubling its presence in the Latin American generics market.  See press release Abbott secured more than 99% of CFR’s common stock via a takeover...

Argentine government adds three vaccines

Argentine president Cristina Fernández de Kirchner has announced the addition of three new vaccines to the country's official immunisation schedule at a cost of $82 million. English version Argentine president Cristina Fernández de Kirchner has announced the addition of three new vaccines to the country's official immunisation schedule at a cost of $82...